共 12 条
- [1] Antibodies against early proteins of human papillomavirus as diagnostic markers for invasive cervical cancer. Meschede W,Zumbach K,Braspenning J,et al. Journal of Clinical Microbiology . 1998
- [2] Polymorphism of the HPV16 E6 gene of cervical carcinomas. Luism AS,Sharonp W,Robera B,et al. International Journal of Oncology . 1995
- [3] Human papillonavirus type 16 DNA sequence. Seedorf K,Krammer G,Durst M,et al. Journal of Virology . 1985
- [4] Molecular diagnosis of cancer. Cotter FE. . 1996
- [5] Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JMM,Jacobs MV,Manos MM,et al. Journal of Paleopathology . 1999
- [6] Differential distribution of sequence variatins in HPV-16 E6. Gostout BS,Zanetta GM,Maleemonkol S,et al. Gynecologic Oncology . 2000
- [7] Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein on an HPV16 tumor model. Greenstone HL,Nieland JD,Visser KE,et al. Proceedings of the National Academy of Sciences of the United States of America . 1998
- [8] Human papillomavirus testing in primary cervical screening. Cuzick J,Szarewski A,Terry G. The Lancet . 1995
- [9] A recombinant vaccinia virus encoding human papillomavirus type 16 and 18, E6 and E7 proteins as in immunotherapy for cervical cancer. Biogsiewicz LK,Fiander A,Nimalo M,et al. The Lancet . 1996
- [10] Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Zenb I,Wilander E,Delius H,et al. Cancer Research . 1998